Merck’s new “miracle” covid drug causes cancerous mutations
Dec 22, 2021 20:18:26 GMT -5
Post by OmegaMan on Dec 22, 2021 20:18:26 GMT -5
Poor hamsters. 
I HATE animal testing!
Merck’s new “miracle” covid drug found to cause cancerous mutations in hamster experiments
Wednesday, December 22, 2021 by: Ethan Huff
Tags: badcancer, badhealth, badmedicine, badscience, Big Pharma, Birth defects, cancer causes, conspiracy, corruption, COVID, Dangerous Medicine, deception, discoveries, men's health, Merck, molnupiravir, pharmaceutical fraud, reproduction, research, truth, women's health
Bypass censorship by sharing this link:
New
www.afinalwarning.com/580053.html
(Natural News) New research out of the University of North Carolina (UNC) found that Merck’s new anti-covid drug molnupiravir causes cancer.
The so-called “miracle” drug, which we reported is really just a rip-off of ivermectin, was applied to hamster cells over the course of 32 days. During this time, it was discovered that the drug induces mutations in DNA.
Study authors wrote that the mutations they observed could “contribute to the development of cancer, or cause birth defects either in a developing fetus or through incorporation into sperm precursor cells.”
It is claimed that molnupiravir only targets dividing cells, which are relatively rare in adults. Still, the drug causes mutations and DNA damage that suggest it could cause tumors and cancer.
Molnupiravir linked to male infertility, admits FDA
The U.S. Food and Drug Administration (FDA) also announced that molnupiravir negatively impacts male fertility.
The New York Times reported that FDA advisers warned that “men wanting to become fathers” may not want to take molnupiravir because the full gamut of its risks “remain poorly understood.”
Merck’s own internal studies identified no risks, of course. The company insists that molnupiravir is completely safe and effective, including against the “Omicron” (Moronic) variant of the Chinese Flu.
The Times reiterated Merck’s claims about molnupiravir, suggesting that it is “expected to work against Omicron,” whatever that is supposed to mean.
Scientists and regulators in Europe, however, are not as convinced. They say that molnupiravir is much less effective than other already available treatments.
Continued at link
I HATE animal testing! Merck’s new “miracle” covid drug found to cause cancerous mutations in hamster experiments
Wednesday, December 22, 2021 by: Ethan Huff
Tags: badcancer, badhealth, badmedicine, badscience, Big Pharma, Birth defects, cancer causes, conspiracy, corruption, COVID, Dangerous Medicine, deception, discoveries, men's health, Merck, molnupiravir, pharmaceutical fraud, reproduction, research, truth, women's health
Bypass censorship by sharing this link:
New
www.afinalwarning.com/580053.html
(Natural News) New research out of the University of North Carolina (UNC) found that Merck’s new anti-covid drug molnupiravir causes cancer.
The so-called “miracle” drug, which we reported is really just a rip-off of ivermectin, was applied to hamster cells over the course of 32 days. During this time, it was discovered that the drug induces mutations in DNA.
Study authors wrote that the mutations they observed could “contribute to the development of cancer, or cause birth defects either in a developing fetus or through incorporation into sperm precursor cells.”
It is claimed that molnupiravir only targets dividing cells, which are relatively rare in adults. Still, the drug causes mutations and DNA damage that suggest it could cause tumors and cancer.
Molnupiravir linked to male infertility, admits FDA
The U.S. Food and Drug Administration (FDA) also announced that molnupiravir negatively impacts male fertility.
The New York Times reported that FDA advisers warned that “men wanting to become fathers” may not want to take molnupiravir because the full gamut of its risks “remain poorly understood.”
Merck’s own internal studies identified no risks, of course. The company insists that molnupiravir is completely safe and effective, including against the “Omicron” (Moronic) variant of the Chinese Flu.
The Times reiterated Merck’s claims about molnupiravir, suggesting that it is “expected to work against Omicron,” whatever that is supposed to mean.
Scientists and regulators in Europe, however, are not as convinced. They say that molnupiravir is much less effective than other already available treatments.
Continued at link
